MIRA Pharmaceuticals (MIRA) News Today $1.22 -0.01 (-0.81%) Closing price 04:00 PM EasternExtended Trading$1.20 -0.01 (-1.23%) As of 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Mira Pharmaceuticals signs binding LOI to acquire SKNY PharmaceuticalsMarch 25 at 9:56 PM | markets.businessinsider.comMIRA Pharmaceuticals in binding LOI to acquire SKNY PharmaceuticalsMarch 25 at 9:56 PM | markets.businessinsider.comMira Pharmaceuticals expands Ketamir-2 development with topical treatmentMarch 13, 2025 | markets.businessinsider.comMIRA Makes Another Pain Management StrideMarch 13, 2025 | msn.com1MIRA : EXCLUSIVE: MIRA Pharmaceuticals Expands Pipeline, Enhances Value Proposition...March 13, 2025 | benzinga.comMira Pharmaceuticals announces approval, initiation of Phase 1 Ketamir-2 trialMarch 4, 2025 | markets.businessinsider.comMIRA Announces Approval of Important TestingMarch 4, 2025 | msn.comEXCLUSIVE: MIRA Pharmaceuticals Kick Starts Human Trial In Israel For Ketamir-2 For Neuropathic PainMarch 4, 2025 | finance.yahoo.comRising High: Exclusive talk with pharmaceutical development company MIRAJanuary 16, 2025 | markets.businessinsider.comHere's Why We're Not Too Worried About MIRA Pharmaceuticals' (NASDAQ:MIRA) Cash Burn SituationJanuary 5, 2025 | finance.yahoo.comMIRA Pharmaceuticals submits IND to FDA for Ketamir-2December 21, 2024 | markets.businessinsider.comMIRA Makes Major StridesDecember 19, 2024 | msn.comErez Aminov Sells 55,410 Shares of MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) StockNovember 28, 2024 | insidertrades.comMira Pharmaceuticals appoints new board memberNovember 23, 2024 | uk.investing.comMIRA Pharmaceuticals Appoints New Board Member and ChairmanNovember 23, 2024 | markets.businessinsider.comMIRA Continues Solid Financial ManagementNovember 13, 2024 | finance.yahoo.comMira Pharmaceuticals announces preclinical data on Ketamir-2October 29, 2024 | markets.businessinsider.comMIRA Pharmaceuticals Shares Surge 40% After Ketamir-2 Excels in Pain Management TrialsOctober 29, 2024 | finance.yahoo.comMIRA Pharmaceuticals' Formulated Shows Greater Efficacy Than FDA-Approved Drug For Chemo-Induced Neuropathic PainOctober 28, 2024 | finance.yahoo.comMIRA says Ketamir-2 outperforms FDA-approved neuropathic pain treatmentsOctober 23, 2024 | markets.businessinsider.comMIRA Continues to Post Outstanding Test ResultsOctober 21, 2024 | msn.comMira Pharmaceuticals (NASDAQ:MIRA) Stock, Short Interest ReportOctober 9, 2024 | benzinga.comSmall Changes… Big Effects! Breakthrough Therapies Are The Name Of The Game For This BiopharmaOctober 3, 2024 | msn.comRodman & Renshaw Initiates Coverage of MIRA Pharmaceuticals (MIRA) with Buy RecommendationOctober 1, 2024 | msn.comWhy Mira Shares Are Trading Higher TodaySeptember 27, 2024 | msn.comMIRA Makes Impressive ProgressSeptember 18, 2024 | msn.comPeering Into Mira Pharmaceuticals's Recent Short InterestSeptember 11, 2024 | benzinga.comBioMedNewsBreaks – Telomir Pharmaceuticals Inc. (NASDAQ: TELO) Appoints Pharmaceutical Innovation Veteran as Chief Scientific AdvisorSeptember 4, 2024 | msn.comMIRA Announces Significant Test ResultsAugust 27, 2024 | msn.comMidday stock movers: Temu Parent, Planet Fitness, MIRA PharmaceuticalsAugust 26, 2024 | msn.comMIRA Pharmaceuticals' Oral Ketamine Analog Achieves Complete Normalization Of Neuropathic Pain In Animal StudiesAugust 26, 2024 | benzinga.comWhy MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving PremarketAugust 26, 2024 | msn.comStocks to Watch: MIRA Pharmaceuticals, Talis BiomedicalAugust 24, 2024 | marketwatch.comMIRA Pharmaceuticals' Shares Soar on Ketamine-Analog Drug Study ResultsAugust 24, 2024 | marketwatch.comMIRA Reports Promising Pre-Clinical Results For Ketamir-2 In Neuropathic Pain Study; Stock UpAugust 24, 2024 | markets.businessinsider.comMIRA Pharmaceuticals, Inc. (K6S.F)August 18, 2024 | finance.yahoo.comMIRA Continues to Reveal Advances in TreatmentAugust 16, 2024 | msn.comIntelliguard, Cencora Partner to Increase Compatibility of RFID-Tagged Medications, Medication Management SystemsAugust 14, 2024 | finance.yahoo.comTELOMIR PHARMACEUTICALS, INC.: Telomir Pharmaceuticals Mourns the Passing of Chairman and CEO Dr. Christopher ChapmanAugust 13, 2024 | finanznachrichten.deMIRA Mira Pharmaceuticals files $100M mixed securities shelfAugust 13, 2024 | msn.comTelomir Pharmaceuticals Mourns the Passing of Chairman and CEO Dr. Christopher ChapmanAugust 12, 2024 | finance.yahoo.comTelomir Pharmaceuticals Chair, CEO Christopher Chapman Passes AwayAugust 12, 2024 | marketwatch.comMIRA Pharmaceuticals regains Nasdaq complianceAugust 10, 2024 | uk.investing.comAscendiant Capital Initiates Coverage of MIRA Pharmaceuticals (MIRA) with Buy RecommendationAugust 7, 2024 | msn.comMIRA Pharmaceuticals, Inc. (MIRA)August 1, 2024 | finance.yahoo.comDow Rebounds Nearly 500 Points; Warren Buffett Unloads Key HoldingJuly 25, 2024 | msn.comMental Health Disorders-Focused MIRA Pharmaceuticals Unveils Additional Preclinical DataJuly 25, 2024 | benzinga.comPre-market Movers: Psyence Biomedical, 2U, Inc., IF Bancorp, MIRA Pharmaceuticals, Predictive OncologyJuly 25, 2024 | finanznachrichten.deStocks Mixed After GDP Data; Software Firm Breaks Out As Nasdaq Falls FurtherJuly 25, 2024 | msn.comWe're Not Very Worried About MIRA Pharmaceuticals' (NASDAQ:MIRA) Cash Burn RateJuly 24, 2024 | finance.yahoo.com Remove Ads Get MIRA Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MIRA and its competitors with MarketBeat's FREE daily newsletter. Email Address MIRA Media Mentions By Week MIRA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MIRA News Sentiment▼0.470.68▲Average Medical News Sentiment MIRA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MIRA Articles This Week▼01▲MIRA Articles Average Week Remove Ads Get MIRA Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MIRA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Aligos Therapeutics News Today Genenta Science News Today Aerovate Therapeutics News Today ESSA Pharma News Today Metagenomi News Today Mural Oncology News Today Entera Bio News Today Assertio News Today I-Mab News Today Pyxis Oncology News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MIRA) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MIRA Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MIRA Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MIRA Stock Free MIRA Stock Alerts